A U.S. Patent Application for “Monoclonal Anti-IL-1RACP Antibodies” was published by MAB Discovery on April 11th, 2019. The present invention is a monoclonal antibody that specifically binds the interleukin 1 receptor type 1, or an antigen binding fragment thereof, comprising: a) a heavy chain variable region (VH) comprising CDR1H, CDR2H and/or CDR3H, wherein the CDR1H region comprises an amino acid sequence selected from the group of SEQ ID NO: 155-231, wherein the CDR2H region comprises an amino acid sequence selected from the group of SEQ ID NO: 232-308, and wherein the CDR3H region comprises an amino acid sequence selected… Learn More